Clinical use of inotropic therapy for heart failure: looking backward or forward? Part II: chronic inotropic therapy.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Circulation

• Publication date

  2003-07-29

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.CIR.0000078349.43742.8APMID 12885733
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Targeting calcium cycling proteins in heart failure through gene transfer

  2003cited by this paper
• Clinical use of inotropic therapy for heart failure: looking backward or forward? Part I: inotropic infusions during hospitalization.

  2003cited by this paper
• Care processes and clinical outcomes of continuous outpatient support with inotropes (COSI) in patients with refractory endstage heart failure.

  2003cited by this paper
• Targeting Phospholamban by Gene Transfer in Human Heart Failure

  2002cited by this paper
• ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary.

  2002cited by this paper
• Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial.

  2002cited by this paper
• Chronic suppression of heart-failure progression by a pseudophosphorylated mutant of phospholamban via in vivo cardiac rAAV gene delivery

  2002cited by this paper
• Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial.

  2002cited by this paper
• Long-term use of a left ventricular assist device for end-stage heart failure.

  2001cited by this paper
• Preferences for quality of life or survival expressed by patients with heart failure.

  2001cited by this paper
• Outpatient parenteral inotropic therapy for advanced heart failure.

  2000cited by this paper
• Myosin heavy chain isoform expression in the failing and nonfailing human heart.

  2000cited by this paper
• Acute Hemodynamic and Clinical Effects of Levosimendan in Patients With Severe Heart Failure

  2000cited by this paper
• A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure. Vesnarinone Trial Investigators.

  1999cited by this paper
• Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: insights from the Flolan International Randomized Survival Trial (FIRST).

  1999cited by this paper
• Oral levosimendan, a novel myofilament calcium sensitizer, is an effective substitute for intravenous inotropic therapy in class IV inotrope-dependent heart failure patients

  1999cited by this paper
• Intermittent 6-month low-dose dobutamine infusion in severe heart failure: DICE multicenter trial.

  1999cited by this paper
• Intermittent dobutamine treatment in patients with chronic refractory congestive heart failure: A randomized, double‐blind, placebo‐controlled study

  1998cited by this paper
• Influence of the novel inotropic agent levosimendan on isometric tension and calcium cycling in failing human myocardium.

  1998cited by this paper
• Resuscitation preferences among patients with severe congestive heart failure: results from the SUPPORT project. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments.

  1998cited by this paper
• Beneficial effects of intermittent home administration of the inotrope/vasodilator milrinone in patients with end-stage congestive heart failure: a preliminary study.

  1998cited by this paper
• Continuous home ambulatory intravenous inotropic drug therapy in severe heart failure: safety and cost efficacy.

  1997cited by this paper
• Clinical Investigations: MiscellaneousHome Inotropic Therapy in Advanced Heart Failure: Cost Analysis and Clinical Outcomes

  1997cited by this paper
• Intermittent inotropic therapy in an outpatient setting: a cost-effective therapeutic modality in patients with refractory heart failure.

  1996cited by this paper
• Eosinophilic myocarditis in heart transplant candidates.

  1996cited by this paper
• Elevation of systemic oxygen delivery in the treatment of critically ill patients.

  1994cited by this paper
• Intermittent infusion of dobutamine in the therapy of severe congestive heart failure-long-term effects and lack of tolerance

  1992cited by this paper
• Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group.

  1991cited by this paper
• Outpatient dobutamine for refractory congestive heart failure: advantages, techniques, and results.

  1991cited by this paper
• Efficacy of medical therapy tailored for severe congestive heart failure in patients transferred for urgent cardiac transplantation.

  1989cited by this paper
• Outpatient dobutamine and dopamine infusions in the management of chronic heart failure: clinical experience in 21 patients.

  1987cited by this paper
• Intermittent, ambulatory dobutamine infusions in patients with severe congestive heart failure.

  1986cited by this paper
• Arrhythmias Associated with Intermittent Outpatient Dobutamine Infusion

  1986cited by this paper
• Intermittent dobutamine hydrochloride infusions in outpatients with chronic congestive heart failure.

  1985cited by this paper

• Incidence of Clinically Significant Ventricular Arrhythmias in Patients on Home Inotrope Infusion in the Contemporary Era: home inotrope and ventricular arrhythmias.

  2025cites this paper
• How to Select Patients for Left Ventricular Assist Devices? A Guide for Clinical Practice

  2023cites this paper
• Prognosis value of Forrester's classification in advanced heart failure patients awaiting heart transplantation

  2022cites this paper
• Criteria for Referral of Patients With Advanced Heart Failure for Specialized Palliative Care.

  2022cites this paper
• Palliative Inotropes in Advanced Heart Failure: Comparing Outcomes Between Milrinone and Dobutamine.

  2022cites this paper
• Beta-blockers and Ambulatory Inotropic Therapy.

  2022cites this paper
• Inotropic therapies in heart failure and cardiogenic shock: an educational review.

  2021cites this paper
• Advanced Heart Failure Patients Supported with Ambulatory Inotropic Therapy: What Defines Success of Therapy?

  2021cites this paper
• Levosimendan prevents doxorubicin-induced cardiotoxicity in time- and dose dependent manner: Implications for inotropy.

  2020cites this paper
• ARGENTINE SOCIETY OF CARDIOLOGY Consensus on Inotropes and Mechanical Circulatory Support

  2020cites this paper
• Management of Acute Heart Failure

  2020cites this paper
• Novel pharmacotherapies for heart failure

  2020cites this paper
• Increase in PKCα Activity during Heart Failure Despite the Stimulation of PKCα Braking Mechanism

  2020cites this paper
• Inotropes Are Not Linked to Increased Mortality in Heart Failure

  2019cites this paper
• Advanced Therapies for Advanced Heart Failure in Women.

  2019cites this paper
• Palliative Inotrope Therapy: A Narrative Review.

  2019cites this paper
• Effects of the cardiac myosin activator Omecamtiv-mecarbil on severe chronic aortic regurgitation in Wistar rats

  2018cites this paper
• Candidate Selection for Durable Mechanical Circulatory Support.

  2018cites this paper
• Effects of intravenous home dobutamine in palliative end‐stage heart failure on quality of life, heart failure hospitalization, and cost expenditure

  2018cites this paper
• Management of Advanced Heart Failure: An Overview

  2018cites this paper
• Is Exercise Training Appropriate for Patients With Advanced Heart Failure Receiving Continuous Inotropic Infusion? A Review

  2018cites this paper
• Levosimendan in high risk patients Undergoing Cardiac Surgery ConSEnSUS Cooperative north Scandinavian Enalapril Survival Study CopErniCUS Carvedilol prospective randomized Cumulative Survival LaiCa Long-Term intermittent administration of Levosimendan in patients With advanced heart Failure LEoDor

  2018cites this paper
• Renal Function and Outcomes With Use of Left Ventricular Assist Device Implantation and Inotropes in End-Stage Heart Failure: A Retrospective Single Center Study

  2017cites this paper
• Mechanical Circulatory Support as a Bridge to Heart Transplantation

  2017cites this paper
• Management of acute heart failure

  2017cites this paper
• Combined heart–liver transplantation for failing Fontan circulation in a late survivor with single‐ventricle physiology

  2017cites this paper
• Biased Agonism at the Angiotensin Receptor: Blocker and Calcium Sensitizer at the Same Time

  2017cites this paper
• Cardiac Myosin Activators in Systolic Heart Failure: More Friend than Foe?

  2016cites this paper
• Palliative Care in Heart Failure.

  2016cites this paper
• An evidence-based review of recent advances in therapy for heart failure with reduced ejection fraction (HFrEF)

  2016cites this paper
• DURABLE MECHANICAL CIRCULATION SUPPORT AS AN ALTERNATIVE TO HEART TRANSPLANTATION

  2016cites this paper
• Advanced practice nursing in pediatric heart failure- therapeutics and models of care

  2016cites this paper
• Home Inotropes and Other Palliative Care.

  2016cites this paper
• Cardiac Myosin Activators for the Treatment of Heart Failure: Stop Now or Push Ahead?

  2016cites this paper
• Advanced heart failure: an appraisal of the potential of levosimendan in this end-stage scenario and some related ethical considerations

  2016cites this paper
• Akute Herzinsuffizienz und kardiogener Schock, Herzbeuteltamponade

  2015cites this paper
• Care for Patients Dying with a Left Ventricular Assist Device

  2015cites this paper
• Intensivtherapie bei akuter Herzinsuffizienz, kardiogenem Schock und Herzbeuteltamponade

  2015cites this paper
• Clinical Characteristics and Outcomes of Intravenous Inotropic Therapy in Advanced Heart Failure

  2015cites this paper
• Team-Based Care for Outpatients with Heart Failure.

  2015cites this paper
• Chronic Inotropic Therapy in the Current Era: Old Wines With New Pairings.

  2015cites this paper
• Glucagon Increases Beating Rate but Not Contractility in Rat Right Atrium. Comparison with Isoproterenol

  2015cites this paper
• Advanced heart failure management and selection for advanced therapies

  2015cites this paper
• Левосимендан: клинические данные, практическое применение и перспективы

  2014cites this paper
• Palliative Care in Advanced Heart Failure

  2014cites this paper
• Inotropes do not increase mortality in advanced heart failure

  2014cites this paper
• Efficacy and safety of the pulsed infusions of levosimendan in outpatients with advanced heart failure (LevoRep) study: a multicentre randomized trial

  2014cites this paper
• Waiting List Management for Heart Transplantation

  2014cites this paper
• An in silico case study of idiopathic dilated cardiomyopathy via a multi-scale model of the cardiovascular system

  2014cites this paper
• Intensive Care in Cardiac Failure

  2014cites this paper
• Inotrope use and outcomes among patients hospitalized for heart failure: impact of systolic blood pressure, cardiac index, and etiology.

  2014cites this paper
• Does renal dysfunction and method of bridging support influence heart transplant graft survival?

  2014cites this paper
• Guidelines for Treatment of Acute Heart Failure (JCS 2011) : Digest Version

  2013cites this paper
• Elevation of Plasma Milrinone Concentrations in Stage D Heart Failure Associated With Renal Dysfunction

  2013cites this paper
• Left Ventricular Assist Devices: From Bridge to Transplant to Destination Therapy

  2013cites this paper
• Positive inotroPic agents for treatment of acute heart failure

  2013cites this paper
• Guidelines for treatment of acute heart failure (JCS 2011).

  2013cites this paper
• Patient selection for cardiac transplant in 2012

  2013cites this paper
• L’insuffisance mitrale chez le cheval : revue de la littérature et comparaison avec la pathologie chez l’homme et chez le chien

  2013cites this paper
• Levosimendan: current data, clinical use and future development

  2013cites this paper
• Cardiac autonomic nerve stimulation in the treatment of heart failure.

  2013cites this paper
• Novel therapies in acute and chronic heart failure.

  2012cites this paper
• Effect of epivascular cardiac autonomic nerve stimulation on cardiac function.

  2012cites this paper
• Cardiac gene therapy in large animals: bridge from bench to bedside

  2012cites this paper
• Cardiorenal syndrome in acute decompensated heart failure

  2012cites this paper
• Patient selection for left ventricular assist devices.

  2011cites this paper
• Lipid-mediated folding/unfolding of phospholamban as a regulatory mechanism for the sarcoplasmic reticulum Ca2+-ATPase.

  2011cites this paper
• Cardiac Assist Devices

  2011cites this paper
• β₂ AR agonists in treatment of chronic heart failure: long path to translation.

  2011cites this paper
• Pharmacologic therapy for New York Heart Association class IV heart failure.

  2011cites this paper
• Contemporary Reviews in Cardiovascular Medicine

  2010cites this paper
• Mechanical Circulatory Support as a Bridge to Transplant or for Destination Therapy

  2010cites this paper
• Are Ventricular Assist Devices Underutilized?

  2010cites this paper
• Role of cardiac resynchronization in end-stage heart failure patients requiring inotrope therapy.

  2010cites this paper
• End-of-Life Options for Patients with Advanced Heart Failure

  2010cites this paper
• Patient selection for left ventricular assist devices

  2010cites this paper
• Asistidores mecánicos: la etapa avanzada de la insuficiencia cardiaca

  2010cites this paper
• Contemporary Reviews in Cardiovascular Medicine Selection of Cardiac Transplantation Candidates in 2010

  2010cites this paper
• Usefulness of cardiac index and peak exercise oxygen consumption for determining priority for cardiac transplantation.

  2010cites this paper
• Management of end-stage heart failure: a perspective on the Arab Gulf states

  2009cites this paper
• Should we use outpatient dobutamine or milrinone?

  2009cites this paper
• Evaluation of the anti-ischemic effects of D-ribose during dobutamine stress echocardiography: a pilot study

  2009cites this paper
• Intermittent Inotropic Infusions Combined With Prophylactic Oral Amiodarone for Patients With Decompensated End-stage Heart Failure

  2009cites this paper
• Challenges for the Basis of Practice Should We Use Outpatient Dobutamine or Milrinone

  2009cites this paper
• Patient selection for left-ventricular assist devices

  2009cites this paper
• β-Adrenergic stimulation and myocardial function in the failing heart

  2009cites this paper
• SERCA2a Gene Transfer Therapy for Heart Failure

  2009cites this paper
• Prognosis on Chronic Dobutamine or Milrinone Infusions for Stage D Heart Failure

  2009cites this paper
• Pharmacologic- and gene therapeutic-based inhibition of PKC α / β enhances cardiac contractility and attenuates heart failure

  2009cites this paper
• Agents with inotropic properties for the management of acute heart failure syndromes. Traditional agents and beyond

  2009cites this paper
• Anesthetic Management and Hemodynamic Management

  2008cites this paper
• Glucagon increases contractility in ventricle but not in atrium of the rat heart.

  2008cites this paper
• Inotropes and Vasopressors: Review of Physiology and Clinical Use in Cardiovascular Disease

  2008cites this paper
• Cardiovascular Disease Inotropes and Vasopressors: Review of Physiology and Clinical Use in

  2008cites this paper
• Current and future considerations in the use of mechanical circulatory support devices.

  2008cites this paper
• Il trattamento con farmaci ad azione inotropa positiva nella gestione del paziente con scompenso cardiaco cronico con frequenti instabilizzazioni

  2008cites this paper
• Evaluation for Ventricular Assist Devices and Cardiac Transplantation

  2008cites this paper
• Disease Inotropes and Vasopressors : Review of Physiology and Clinical Use in Cardiovascular

  2008cites this paper
• Early Medical Management of Acute Heart Failure Syndromes

  2008cites this paper
• Sodium nitroprusside for advanced low-output heart failure.

  2008cites this paper